Ifp Advisors, Inc Vascular Biogenics Ltd. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021
SELL
$1.94 - $2.55 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021
BUY
$1.69 - $2.67 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021
BUY
$1.79 - $2.91 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021
BUY
$1.07 - $2.0 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020
BUY
$1.11 - $1.4 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020
BUY
$1.12 - $1.63 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020
BUY
$0.96 - $1.57 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020
BUY
$1.1 - $1.32 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019
BUY
$1.11 - $1.42 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
SELL
$0.94 - $1.75 $799 - $1,487
-850 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$2.05 - $3.0 $38,369 - $56,151
-18,717 Reduced 95.66%
850 $0
Q1 2018

Jun 03, 2019
BUY
$2.27 - $8.5 $42,487 - $159,094
18,717 Added 2202.0%
19,567 $139,000
Q1 2018

May 09, 2018
SELL
$2.27 - $8.5 $42,487 - $159,094
-18,717 Reduced 95.66%
850 $0
Q4 2017

Jan 24, 2018
BUY
$5.65 - $9.0 $85,411 - $136,053
15,117 Added 339.71%
19,567 $0
Q3 2017

Oct 30, 2017
SELL
$4.15 - $7.2 $7,885 - $13,680
-1,900 Reduced 29.92%
4,450 $27,000
Q2 2017

Jun 03, 2019
SELL
N/A
-3,650 Reduced 36.5%
6,350 $28,000
Q1 2017

Jun 03, 2019
SELL
N/A
-16,550 Reduced 62.34%
10,000 $55,000
Q4 2016

Jun 03, 2019
SELL
N/A
-5,550 Reduced 17.29%
26,550 $129,000
Q2 2016

Jun 03, 2019
BUY
N/A
32,100
32,100 $148,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email